dentalcorp Announces Presentation at Jefferies Healthcare Conference
01 Jun 2023
TORONTO--(BUSINESS WIRE)--dentalcorp Holdings Ltd. ("dentalcorp" or the "Company") (TSX: DNTL), Canada's largest and one of North America's fastest growing networks of dental practices, announced today that senior management will present at the Jefferies Healthcare Conference in New York on Thursday, June 8th, 2023, at 2:00 pm ET.
Interested parties can access the presentation by clicking on the following link: https://wsw.com/webcast/jeff281/dntl/1856140
The presentation will also be accessible by going to 'Events and Presentations' on the Investor Relations section of the Company's website here:
https://www.investors.dentalcorp.ca/site/investor-events-presentations
About dentalcorp
dentalcorp is Canada's largest and one of North America's fastest growing networks of dental practices, committed to advancing the overall well-being of Canadians by delivering the best clinical outcomes and unforgettable experiences. dentalcorp acquires leading dental practices, uniting its network in a common goal: to be Canada's most trusted healthcare network. Leveraging its industry-leading technology, know-how and scale, dentalcorp offers professionals the unique opportunity to retain their clinical autonomy while unlocking their potential for future growth. To learn more, visit dentalcorp.ca
SOURCE dentalcorp Holdings Ltd.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.